Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2p1u | 4TN | Retinoic acid receptor RXR-alpha |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2p1u | 4TN | Retinoic acid receptor RXR-alpha | / | 1.000 | |
2p1v | 5TN | Retinoic acid receptor RXR-alpha | / | 0.765 | |
1rdt | L79 | Retinoic acid receptor RXR-alpha | / | 0.614 | |
2p1t | 3TN | Retinoic acid receptor RXR-alpha | / | 0.614 | |
1k74 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.598 | |
1fby | REA | Retinoic acid receptor RXR-alpha | / | 0.596 | |
3fc6 | REA | Retinoic acid receptor RXR-alpha | / | 0.595 | |
1xiu | REA | Retinoic acid receptor RXR | / | 0.594 | |
3uvv | REA | Retinoic acid receptor RXR-alpha | / | 0.592 | |
1mzn | BM6 | Retinoic acid receptor RXR-alpha | / | 0.589 | |
4m8e | 29V | Retinoic acid receptor RXR-alpha | / | 0.588 | |
1fm9 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.585 | |
1fm6 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.584 | |
4k4j | 1O8 | Retinoic acid receptor RXR-alpha | / | 0.584 | |
4k6i | 9RA | Retinoic acid receptor RXR-alpha | / | 0.583 | |
4m8h | R4M | Retinoic acid receptor RXR-alpha | / | 0.575 | |
1uhl | MEI | Retinoic acid receptor RXR-beta | / | 0.574 | |
3oap | REA | Retinoic acid receptor RXR-alpha | / | 0.570 | |
1xls | REA | Retinoic acid receptor RXR-alpha | / | 0.567 | |
1mvc | BM6 | Retinoic acid receptor RXR-alpha | / | 0.564 | |
2acl | REA | Retinoic acid receptor RXR-alpha | / | 0.564 | |
3fal | REA | Retinoic acid receptor RXR-alpha | / | 0.553 | |
2bxq | IMN | Serum albumin | / | 0.512 | |
1ppj | ANY | Cytochrome b | / | 0.503 | |
2xvv | 9DN | Serum albumin | / | 0.500 | |
3p9t | TCL | Repressor | / | 0.496 | |
4f4d | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.496 | |
3cz0 | 9OD | Pheromone-binding protein ASP1 | / | 0.495 | |
5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.488 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.486 | |
3d78 | NBB | Pheromone-binding protein ASP1 | / | 0.485 | |
2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.484 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.483 | |
4ktl | 1CQ | Cytochrome P450 | / | 0.482 | |
4iw8 | KN3 | Estrogen receptor | / | 0.481 | |
1txt | CAA | HMG-CoA synthase | / | 0.480 | |
1jom | FFO | Dihydrofolate reductase | 1.5.1.3 | 0.479 | |
1ly4 | COQ | Dihydrofolate reductase | 1.5.1.3 | 0.479 | |
2p15 | EZT | Estrogen receptor | / | 0.479 | |
3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.479 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.479 | |
3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.478 | |
3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.477 | |
4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.476 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.475 | |
1ia4 | TQ6 | Dihydrofolate reductase | 1.5.1.3 | 0.475 | |
2wpw | ACO | Orf14 | / | 0.475 | |
3b9l | AZZ | Serum albumin | / | 0.475 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.475 | |
2agv | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.474 | |
3d74 | NBB | Pheromone-binding protein ASP1 | / | 0.474 | |
4ku5 | DCC | 3-oxoacyl-[ACP] synthase III | / | 0.473 | |
4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.473 | |
3bfa | 9OD | Odorant binding protein ASP1 | / | 0.472 | |
3t3q | 9PL | Cytochrome P450 2A6 | 1.14.13 | 0.472 | |
1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.471 | |
1og5 | SWF | Cytochrome P450 2C9 | / | 0.471 | |
2xvw | 9NR | Serum albumin | / | 0.471 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.471 | |
3h0a | 9RA | Retinoic acid receptor RXR-alpha | / | 0.471 | |
1cqp | 803 | Integrin alpha-L | / | 0.470 | |
1xdk | REA | Retinoic acid receptor beta | / | 0.470 | |
2m56 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.470 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.470 | |
3hcr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.470 | |
3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.470 | |
2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.469 | |
2xlr | FAD | Putative flavin-containing monooxygenase | / | 0.468 | |
3inv | C50 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.468 | |
3uic | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.468 | |
4ktf | 1TM | Cytochrome P450 | / | 0.468 | |
1e7a | PFL | Serum albumin | / | 0.467 | |
1s3y | TQT | Dihydrofolate reductase | 1.5.1.3 | 0.467 | |
1y2b | DEE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.467 | |
2ewp | TXF | Estrogen-related receptor gamma | / | 0.467 | |
3d75 | NBB | Pheromone-binding protein ASP1 | / | 0.467 | |
3iro | 2CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.467 | |
4e6a | 0O9 | Mitogen-activated protein kinase 14 | / | 0.467 | |
1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.466 | |
1kzj | CB3 | Thymidylate synthase | / | 0.466 | |
3kr6 | UD1 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.466 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.465 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.465 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.465 | |
4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.465 | |
1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.464 | |
2bxm | IMN | Serum albumin | / | 0.464 | |
2qd3 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.464 | |
3d84 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.464 | |
3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.464 | |
3qg2 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.464 | |
3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.464 | |
4j8t | DOG | Uncharacterized PhzA/B-like protein PA3332 | / | 0.464 | |
4xe6 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.464 | |
3qak | UKA | Adenosine receptor A2a | / | 0.464 | |
1ai9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.463 | |
1ykd | CMP | Adenylate cyclase | / | 0.463 | |
2acw | UPG | Glycosyltransferase | / | 0.463 | |
3up0 | D7S | aceDAF-12 | / | 0.463 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.463 | |
1olm | VTQ | SEC14-like protein 2 | / | 0.462 | |
3d77 | NBB | Pheromone-binding protein ASP1 | / | 0.462 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.462 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.462 | |
1x2h | LPA | Lipoate-protein ligase A | 6.3.1.20 | 0.461 | |
2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.461 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.461 | |
3is9 | AC7 | Gag-Pol polyprotein | 2.7.7.49 | 0.461 | |
3sp9 | IL2 | Peroxisome proliferator-activated receptor delta | / | 0.461 | |
4zju | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.461 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.461 | |
2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.460 | |
4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.460 | |
4dvi | 2IW | Tankyrase-1 | 2.4.2.30 | 0.460 | |
4ejh | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.460 | |
4zqc | F6F | Tryptophan synthase alpha chain | / | 0.460 | |
1osv | CHC | Bile acid receptor | / | 0.459 | |
3c3x | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.459 | |
3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.459 | |
3reo | EUG | (Iso)eugenol O-methyltransferase | 2.1.1.146 | 0.459 | |
4apu | A2K | Progesterone receptor | / | 0.459 | |
1bvr | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.458 | |
2uxi | G50 | HTH-type transcriptional regulator TtgR | / | 0.458 | |
3fhx | PXL | Pyridoxal kinase | 2.7.1.35 | 0.458 | |
3fwf | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.458 | |
4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
5akk | 1P8 | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.458 | |
1fm7 | DFV | Chalcone--flavonone isomerase 1 | 5.5.1.6 | 0.457 | |
1mab | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.457 | |
2dqs | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.457 | |
2dw4 | FAD | Lysine-specific histone demethylase 1A | 1 | 0.457 | |
2h9i | EAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.457 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.457 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.457 | |
4bmp | FMN | Protein NrdI | / | 0.457 | |
4hu1 | V13 | Carbonic anhydrase 13 | 4.2.1.1 | 0.457 | |
5ai5 | BSU | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.457 | |
3rfm | CFF | Adenosine receptor A2a | / | 0.457 | |
1rx1 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
3ans | S38 | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.456 | |
3pqb | VGP | Putative oxidoreductase | / | 0.456 | |
3sgv | 2BJ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.456 | |
3uhm | RFN | UDP-3-O-acyl-N-acetylglucosamine deacetylase | / | 0.456 | |
4g1y | 0VO | Vitamin D3 receptor A | / | 0.456 | |
4iah | 1DX | Alr2278 protein | / | 0.456 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.456 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.456 | |
1l2j | ETC | Estrogen receptor beta | / | 0.455 | |
1xdd | AAY | Integrin alpha-L | / | 0.455 | |
1zga | HMK | Isoflavone 4'-O-methyltransferase | / | 0.455 | |
2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.455 | |
2qd5 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.455 | |
2z97 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.455 | |
3dd1 | 25D | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.455 | |
3pe6 | ZYH | Monoglyceride lipase | / | 0.455 | |
3qly | 55V | Uncharacterized protein | / | 0.455 | |
4iq7 | 1G9 | Mycocyclosin synthase | 1.14.21.9 | 0.455 | |
1j3j | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.454 | |
1m78 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
2oci | TYC | Valacyclovir hydrolase | 3.1 | 0.454 | |
2rh9 | IGP | Tryptophan synthase alpha chain | / | 0.454 | |
3bxx | QUE | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.454 | |
3gw9 | VNI | Lanosterol 14-alpha-demethylase | / | 0.454 | |
3l6j | Z90 | Alr2278 protein | / | 0.454 | |
3lak | KR1 | Gag-Pol polyprotein | 2.7.7.49 | 0.454 | |
4bqp | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.454 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.454 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.454 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.453 | |
1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.453 | |
1tg5 | 645 | 4-hydroxyphenylpyruvate dioxygenase | 1.13.11.27 | 0.453 | |
2azy | CHD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.453 | |
2o4r | VD5 | Vitamin D3 receptor | / | 0.453 | |
3dol | GWI | Pol protein | / | 0.453 | |
4elg | 52J | Dihydrofolate reductase | / | 0.453 | |
4lxj | LAN | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.453 | |
5doz | NDP | JamJ | / | 0.453 | |
4zj8 | SUV | Orexin receptor type 1 | / | 0.453 | |
1fko | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.452 | |
1nhz | 486 | Glucocorticoid receptor | / | 0.452 | |
1qoq | IGP | Tryptophan synthase alpha chain | / | 0.452 | |
1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.452 | |
2iko | 7IG | Renin | 3.4.23.15 | 0.452 | |
3ar7 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.452 | |
3q0g | BCO | Probable enoyl-CoA hydratase echA8 | 4.2.1.17 | 0.452 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.452 | |
4u9z | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.452 | |
4xbf | FAD | Lysine-specific histone demethylase 1A | 1 | 0.452 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.452 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.452 | |
1kl2 | FON | Serine hydroxymethyltransferase | / | 0.451 | |
1lso | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.451 | |
1rf7 | DHF | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
2bxo | OPB | Serum albumin | / | 0.451 | |
2pnu | ENM | Androgen receptor | / | 0.451 | |
3gwf | FAD | Cyclohexanone monooxygenase | / | 0.451 | |
3nn6 | HNK | 6-hydroxy-L-nicotine oxidase | / | 0.451 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
3vso | EK1 | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
4at0 | FAD | Possible succinate dehydrogenase | / | 0.451 | |
4g48 | PZB | Mycocyclosin synthase | 1.14.21.9 | 0.451 | |
4xoi | GTP | Transforming protein RhoA | / | 0.451 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.451 | |
1fmj | RTL | Retinol dehydratase | / | 0.450 | |
1hb1 | OCV | Isopenicillin N synthase | 1.21.3.1 | 0.450 | |
1zdw | FLV | Prenyltransferase | / | 0.450 | |
2ij7 | TPF | Mycocyclosin synthase | 1.14.21.9 | 0.450 | |
2wd8 | VGF | Pteridine reductase | / | 0.450 | |
3d73 | NBB | Pheromone-binding protein ASP1 | / | 0.450 | |
3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.450 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.450 | |
3p3z | P3Z | Putative cytochrome P450 | / | 0.450 | |
3wix | LC3 | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.450 | |
4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.450 | |
4iae | 1DX | Alr2278 protein | / | 0.450 | |
4kbn | 25U | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
5kf1 | ACO | Predicted acetyltransferase | / | 0.450 | |
5g53 | NEC | Adenosine receptor A2a | / | 0.450 | |
1trg | CB3 | Thymidylate synthase | / | 0.449 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
2qbn | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
2zb4 | 5OP | Prostaglandin reductase 2 | 1.3.1.48 | 0.449 | |
3cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
3cse | N22 | Uncharacterized protein | / | 0.449 | |
3dya | PZL | Gag-Pol polyprotein | 2.7.7.49 | 0.449 | |
3qdd | 94M | Heat shock protein HSP 90-alpha | / | 0.449 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.449 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.449 | |
4pkl | 1GH | Uncharacterized protein | / | 0.449 | |
4trn | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.449 | |
1iwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.448 | |
2r6j | NDP | Eugenol synthase 1 | 1.1.1.318 | 0.448 | |
3a3y | OBN | Sodium/potassium-transporting ATPase subunit alpha | / | 0.448 | |
3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.448 | |
3dok | GWJ | Pol protein | / | 0.448 | |
3gbk | 2PQ | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
3lkh | LT6 | Genome polyprotein | 2.7.7.48 | 0.448 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.448 | |
4dbz | NDP | Putative ketoacyl reductase | 1.3.1 | 0.448 | |
4g47 | TZF | Mycocyclosin synthase | 1.14.21.9 | 0.448 | |
5c1m | CLR | Mu-type opioid receptor | / | 0.448 | |
1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.447 | |
1ppj | SMA | Cytochrome b | / | 0.447 | |
2h2q | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.447 | |
3h3t | 16H | Collagen type IV alpha-3-binding protein | / | 0.447 | |
3own | 3OW | Renin | 3.4.23.15 | 0.447 | |
3qj5 | 022 | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.447 | |
3ufn | ROC | Gag-Pol polyprotein | / | 0.447 | |
3vev | 0H4 | Glucokinase | 2.7.1.2 | 0.447 | |
3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.447 | |
4dqu | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.447 | |
4lxh | C1E | Alpha/beta hydrolase fold | / | 0.447 | |
6cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.447 | |
3uza | T4G | Adenosine receptor A2a | / | 0.447 | |
1nce | CB3 | Thymidylate synthase | / | 0.446 | |
1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.446 | |
1t86 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
1tka | N3T | Transketolase 1 | 2.2.1.1 | 0.446 | |
2fzh | DH1 | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.446 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
3upk | UD1 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.446 | |
3w5t | LHP | Vitamin D3 receptor | / | 0.446 | |
4h4m | 494 | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.446 | |
4ktk | KTK | Cytochrome P450 | / | 0.446 | |
5hs1 | VOR | Lanosterol 14-alpha demethylase | / | 0.446 | |
1a27 | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.445 | |
1ie8 | KH1 | Vitamin D3 receptor | / | 0.445 | |
1iwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
2fzi | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
2iod | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.445 | |
2op1 | 8PC | Enoyl-ACP reductase | / | 0.445 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.445 | |
3irn | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.445 | |
3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.445 | |
3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.445 | |
3wrj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
4a8v | 2AN | Major pollen allergen Bet v 1-J | / | 0.445 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.445 | |
4egn | TWO | Cytochrome P450 | / | 0.445 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.445 | |
4uyf | 73B | Bromodomain-containing protein 2 | / | 0.445 | |
5d7p | OCZ | NAD-dependent protein deacetylase sirtuin-2 | 3.5.1 | 0.445 | |
5d5b | CAU | Beta-2 adrenergic receptor | / | 0.445 | |
1eio | GCH | Gastrotropin | / | 0.444 | |
1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.444 | |
1jtu | LYB | Thymidylate synthase | / | 0.444 | |
1l0l | FMX | Cytochrome b | / | 0.444 | |
1xdu | SFG | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.444 | |
1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.444 | |
2aqi | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
2hrc | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.444 | |
2j9l | ATP | H(+)/Cl(-) exchange transporter 5 | / | 0.444 | |
2nq8 | ZID | Enoyl-ACP reductase | / | 0.444 | |
2vig | FAD | Short-chain specific acyl-CoA dehydrogenase, mitochondrial | 1.3.8.1 | 0.444 | |
2xk8 | 5R1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.444 | |
3exn | ACO | Probable acetyltransferase | / | 0.444 | |
3lan | KBT | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
3vsp | EK8 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
4ap1 | NAP | Steroid monooxygenase | / | 0.444 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.444 | |
4iui | 1GQ | Estrogen receptor | / | 0.444 | |
4k4f | K4F | Tankyrase-1 | 2.4.2.30 | 0.444 | |
4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.444 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.444 | |
4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.444 | |
4xsr | UPG | Alr3699 protein | / | 0.444 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.444 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.444 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.444 | |
3rey | XAC | Adenosine receptor A2a | / | 0.444 | |
1flm | FMN | FMN-binding protein | / | 0.443 | |
1tdr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
1wrl | TFP | Troponin C, slow skeletal and cardiac muscles | / | 0.443 | |
1zc3 | GNP | Ras-related protein Ral-A | / | 0.443 | |
1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.443 | |
2hko | FAD | Lysine-specific histone demethylase 1A | 1 | 0.443 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.443 | |
2npn | SAM | Putative cobalamin synthesis related protein | / | 0.443 | |
2rqf | JH3 | Hemolymph juvenile hormone binding protein | / | 0.443 | |
2tsc | CB3 | Thymidylate synthase | / | 0.443 | |
2vbp | VB1 | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
3ar5 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.443 | |
3eig | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3el9 | DR7 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
3elm | 24F | Collagenase 3 | 3.4.24 | 0.443 | |
3frq | ERY | Erythromycin resistance repressor protein | / | 0.443 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.443 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.443 | |
3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
3zv6 | 4HB | Cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase | 1.3.1.56 | 0.443 | |
4c71 | 7RD | 3-oxoacyl-ACP synthase | / | 0.443 | |
4dm6 | TTB | Retinoic acid receptor beta | / | 0.443 | |
4g2g | TDH | Mycocyclosin synthase | 1.14.21.9 | 0.443 | |
4gue | QCT | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.443 | |
4h4o | 506 | Gag-Pol polyprotein | 2.7.7.49 | 0.443 | |
4hyf | 1AK | Tankyrase-2 | 2.4.2.30 | 0.443 | |
4m2x | TMQ | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
4ruo | BIV | Vitamin D3 receptor A | / | 0.443 | |
4xym | COA | Acyl-CoA synthetase (NDP forming) | / | 0.443 | |
1hvi | A77 | Protease | / | 0.442 | |
1kqu | BR4 | Phospholipase A2, membrane associated | / | 0.442 | |
1noo | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
1oc1 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
1t87 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
2a1m | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
2fgk | ATP | Alpha-hemolysin translocation ATP-binding protein HlyB | / | 0.442 | |
2nv6 | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.442 | |
2pnj | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.442 | |
3ar6 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.442 | |
3cyz | 9OD | Pheromone-binding protein ASP1 | / | 0.442 | |
3nx4 | NAP | Putative oxidoreductase | / | 0.442 | |
3pld | F90 | Endothiapepsin | 3.4.23.22 | 0.442 | |
3pm0 | BHF | Cytochrome P450 1B1 | / | 0.442 | |
3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.442 | |
3s79 | ASD | Aromatase | 1.14.14.14 | 0.442 | |
3x04 | GNP | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 2.7.1.149 | 0.442 | |
4a2j | AS0 | Progesterone receptor | / | 0.442 | |
4dsc | A8S | Abscisic acid receptor PYL3 | / | 0.442 | |
4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.442 | |
4jqh | 1MF | Alr2278 protein | / | 0.442 | |
5je2 | SAH | Methyl transferase | / | 0.442 | |
1a4i | NDP | C-1-tetrahydrofolate synthase, cytoplasmic | 1.5.1.5 | 0.441 | |
1cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1d3h | A26 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.441 | |
1dif | A85 | Gag-Pol polyprotein | / | 0.441 | |
1fml | RTL | Retinol dehydratase | / | 0.441 | |
1geb | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
1ikv | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.441 | |
1knu | YPA | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
1pp9 | SMA | Cytochrome b | / | 0.441 | |
1vj3 | TAB | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
2b04 | CHO | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.441 | |
2ji9 | TPW | Oxalyl-CoA decarboxylase | 4.1.1.8 | 0.441 | |
2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.441 | |
2w4q | CBW | Prostaglandin reductase 2 | 1.3.1.48 | 0.441 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.441 | |
3bgi | SAH | Thiopurine S-methyltransferase | 2.1.1.67 | 0.441 | |
3bjh | NBB | Odorant binding protein ASP1 | / | 0.441 | |
3cd2 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
3d4p | NAD | L-lactate dehydrogenase 1 | 1.1.1.27 | 0.441 | |
3fwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
3ixp | 834 | Ecdysone receptor | / | 0.441 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
3qlz | QLZ | Uncharacterized protein | / | 0.441 | |
3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.441 | |
3um6 | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.441 | |
3v1s | 0LH | Strictosidine synthase | 4.3.3.2 | 0.441 | |
4kd7 | 9DR | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
4wdb | 2AM | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | 3.1.4.37 | 0.441 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
1fp1 | HCC | Isoliquiritigenin 2'-O-methyltransferase | / | 0.440 | |
1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
1q1r | FAD | Putidaredoxin reductase | 1.18.1.5 | 0.440 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.440 | |
1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.440 | |
1x8l | OXR | Retinol dehydratase | / | 0.440 | |
1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.440 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.440 | |
2feu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
2ivi | ACW | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.440 | |
3eta | 351 | Insulin receptor | 2.7.10.1 | 0.440 | |
3nmh | PYV | Abscisic acid receptor PYL2 | / | 0.440 | |
3nxe | 2NC | Protease | / | 0.440 | |
3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.440 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.440 | |
3tjs | D0R | Cytochrome P450 3A4 | / | 0.440 | |
3tky | N7I | (Iso)eugenol O-methyltransferase | 2.1.1.146 | 0.440 | |
3um5 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.440 | |
3vtd | TKD | Vitamin D3 receptor | / | 0.440 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.440 | |
3zu2 | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.440 | |
4ele | 31I | Dihydrofolate reductase | / | 0.440 | |
4euf | NAD | Trans-2-enoyl-CoA reductase [NADH] | / | 0.440 | |
4g3r | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
4ge4 | 0KE | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.440 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.440 | |
4ite | TEY | Vitamin D3 receptor | / | 0.440 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.440 | |
4jv6 | 18F | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.440 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.440 | |
4qgi | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
4x5f | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
5hwr | COA | Hydroxymethylglutaryl-CoA synthase | / | 0.440 |